Theruptor Novo, a novel wound dressing in the management of infected diabetic foot ulcer: two case reports

India is the world's center for diabetes, with an estimated 77 million adults over the age of 18 having type 2 diabetes and nearly 25 million are pre-diabetics. Approximately 15-20% of diabetic patients will suffer from diabetic foot ulcer at least once in their lifetime which can also lead to deformity and amputation if timely intervention is not done. The presence of at least two classic signs of inflammation or purulence is the basis of clinical diagnosis of diabetic foot infection and it usually presents with mono/polymicrobial etiology. The surgeon must know the course of the infection, principles of non-healing wound management, and biomechanics of the foot for an optimal outcome. We described 2 case reports who presented with non-healing infected wounds. Healing was achieved through multidisciplinary team approach, patient education about diabetes, off-loading regime and regular wound dressing using Theruptor Novo.